Cite

HARVARD Citation

    Harvey, M. et al. (2021). Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N‐activating mutation. Pediatric blood & cancer. 68 (6), p. n/a. [Online]. 
  
Back to record